Acute MI treatment Roger Suss MD CCFP(EM) Lecturer Dept of Family Medicine University of Manitoba.

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Patient Oriented Therapy for STE-MI
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI )
GUSTO-IV AMI G lobal U se of S trategies T o Open O ccluded Coronary Arteries in AMI.
BLOOD PRESSURE MANAGEMENT IN ACUTE STROKE
Acute Coronary Syndromes Jason Ryan, M.D.. Acute Coronary Syndromes Unstable Angina + Non-ST-Elevation MI + ST-Elevation MI Acute Coronary Syndromes (ACS)
Acute Coronary Syndrome
ST Elevation Myocardial Infarction (STEMI)
Coronary Artery Disease
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
Coronary Artery Disease Megan McClintock. Coronary Artery Disease Definition Etiology/Pathophysiology Risk Factors –Unmodifiable –Modifiable Signs & symptoms.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.
Ischemic Heart Disease Group of diseases Most common cause of death in developed countries Terminology: 1.Angina pectoris 2.Myocardial infarction 3.Sudden.
Myocardial Infarction
Bojana Gardijan 4th year March 16, 2010 Mentor: A. Žmegač Horvat.
Scenario 1Scenario 1  58 year old man  30 minute history of severe chest pain, 10/10, radiating to jaw, not relieved by anything, associated with sweating.
Dr. Hussam F. Al-Faleh Associate Professor of Cardiac Sciences.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
Leadership. Knowledge. Community. Canadian Cardiovascular Society Antiplatelet Guidelines ANTIPLATELET THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Ten Points to Remember from the 2007 STEMI Guideline Update Based on the 2007 Focused Update of the 2004 Guidelines for the Management of Patients With.
ACS and Thrombosis in the Emergency Setting
Amy Gutman MD EMS Medication Director
Case #1: AMI PRESENTED BY AMI ALANIZ. Present Illness  53 year old white male  chest discomfort while playing tennis  became crushing sensation in.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
Acute STEMI: current approach
Number Needed to Treat. End Points Baseline Risk is the risk associated with a particular condition Baseline Risk is the risk associated with a particular.
The Incredible Heart APL3 Who sketched this?. Blood supply to the Heart Supplied to the heart muscle (myocardium) by the coronary arteries Supplied to.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Myocardial Ischemia: Concepts in Management Topics in Clinical Medicine February 14, 2007.
ANGINA PECTORIS Tb Tuberculosis Carl Matol, RN. ANGINA-to choke CLASSIC/STABLE ANGINA Due to insufficiency of O2 supply against myocardial demand Accumulated.
Acute Coronary Syndrome What is Acute Coronary Syndrome ? How can I look at an EKG and tell what part of the heart is affected ? What do ICU RNs need to.
Acute Coronary Syndromes
Does early beta-blockade decrease mortality in STEMI?
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
ANTI-COAGULATION. ENOXAPARIN DOSING Obesity (BMI >= 40 kg/m2) – may increase prophylactic dose by 30% such as in bariatric surgery Abdominal Surgery ….
Coronary Heart Disease. Coronary Circulation Left Coronary Artery –Anterior descending –Circumflex Right Coronary Artery –Posterior descending Veins –Small,
Myocardial Infarction Angina Pectoris What is an MI?
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Acute Coronary Syndrome
Cardiac causes of cardiac arrest
Copyright © 2011 American Medical Association. All rights reserved.
Risk stratification in ACS F.Shakib .cardiologigst
Ischemic Heart Disease
T1: ACS Treatment Tutoring
T1: Post ACS Treatment Tutoring
CHEST PAIN.
Management of ST-Elevation Myocardial Infarction
Ischaemic Heart Disease Acute Coronary Syndrome
Unstable Angina and Non–ST Elevation Myocardial Infarction
Chapter 28 Management of Patients With Coronary Vascular Disorders
American College of Cardiology Presented by Dr. Michel R. Le May
Acute Coronary Syndrome (1)
The recommended approach to patients with chronic obstructive pulmonary disease (COPD) presenting with dyspnoea. The recommended approach to patients with.
Inferior/Right Ventricular Infarction
Myocardial Infarction
Management of AMI in patients presenting with STEMI
Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment – Part 2: ST-Segment Elevation.
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Acute MI treatment Roger Suss MD CCFP(EM) Lecturer Dept of Family Medicine University of Manitoba

AMI Case study 65 year old man with crushing chest pain for 60 minutes DM, HTN, no allergies BP175/105, HR 115 O2 saturation 97% RA EKG shows anterior STEMI

Pathophysiology of an Myocardial Infarction Chronic plaque Acute rupture and thrombosis Myocardial hypoperfusion/hypoxia Myocardial tissue necrosis Remodeling with scar tissue

Increase pressure Increase oxygen carrying capacity Decrease obstruction/Increase flow Decrease oxygen demand Pathophysiology of an Myocardial Infarction

Increase oxygen carrying capacity Decrease obstruction Decrease oxygen demand Pathophysiology of an Myocardial Infarction Extra oxygen?Extra Hb? Fibrinolytics,PCI (percutaneous coronary intervention) ASA, Heparin, Clopidogrel, GIIb/IIIa inhibitors Nitrates,BetaBlockers, Analgesics,Rest

American Heart Association evidence based guideline 2004/2007 on STEMI and 2007 guideline on NSTEMI Level A = definitely Level B = probably Level C = possibly Class I = should Class II = could Class III = dont

Effectiveness of definitely should treatments 30 day mortality from acute MI ~10% ASA Mortality ARR ~2% NNT 50 ASA and lytics Mortality ARR~4% NNT 25 ASA and PCI Mortality ARR~6% NNT 17 Adding Clopidogrel ARR another~0.5% NNT200 Adding Heparin to ASA NNT unclear

Mortality over time Stenestrand and Wallentin. Arch Intern Med 2003

Effectiveness of Fibrinolytics Mortality from acute MI ~10% ARR 2% NNT 50 Decreasing effectiveness of 0.2% each hour ie by 5 hours ARR 1%

Lytics ARR per 1000

ASA 160mg chewed Definitely shouldUnless –Sensitivity (use clopidogrel instead) –Acute hemorrhage Definitely should add PPI if risk of GI bleeding

Nitroglycerine sl or iv Possibly should for –Pain –Hypertension –Pulmonary edema Probably dont if –Phosphodiesterase inhibitor recently –BP <90 sys –HR 100 –Suspected RV infarct

Bed rest Possibly should

Oxygen Probably should if O2<90% Otherwise possibly could

Morphine (2-4mg q5-15 min) Possibly should for –Pain uncontrolled with NTG and other Tx Contraindications –Sensitivity –Severe hypotension

Heparin Definitely should –UFH if PCI or CABG planned, or if CRI, or after lytics in elderly –Otherwise Enoxaparin Unless acute hemorrhage or high risk In NSTEMI RRR ~33% for death or MI at 5 days. Most of the benefits of the various anticoagulants are short term, however, and are not maintained on a long-term basis. RR [CI]

Clopidogrel 75mg daily Definitely should NNT 167 (COMMIT-CCS2) Definitely could load with 300mg if age <75 Unless CABG considered likely

GP IIa/IIIb inhibitors Probably could (as part of PCI)

Beta Blockers (Metoprolol) Definitely should start orally within 24 hours Definitely dont give acutely if –Shock –Heart failure –Heart block –Active asthma/COPD Probably could give IV acutely if no contraindications Probably should give verapamil or diltiazem as alternatives if active asthma or allergy

Oral ACE inhibitor within 24 hours Definitely should if –Pulmonary edema –LVEF < 40% Unless hypotension or other contraindications ARB if ACE not tolerated

Stop all NSAIDs except ASA Possibly should

Reperfusion (lytics or PCI) (WRHA guidelines) Definitely should if –ST > or = to 0.1mV in 2 adjacent leads or new LBBB –Pain onset <12 hours –Current pain

Reperfusion by PCI (WRHA guidelines) Definitely should if –Can be done in contact to balloon time of <60 min –Cardiogenic shock –Pulmonary edema –Recurrent VF/VT –STEMI dx in doubt –Pain or ST elevation remains >50% at 60 minutes after lytics –Contraindication to lytics Definitely dont use lytics if –High bleeding risk (see list) Probably dont use lytics if –Moderate bleeding risk (see list) –Presenting BP >180/110

Reperfusion by PCI in NSTEMI (AHA) Definitely should if –Cardiogenic shock –Recurrent VF/VT –Ongoing pain/symptoms despite aggressive medical management

Treatment? ASA - yes PCI? Oxygen? NTG sl iv? B blocker? Heparin? Morphine? Clopidogrel? GIIa/IIIb inhibitor?

WRHA STEMI care map

AMI Case study 65 year old man with crushing chest pain for 60 minutes DM, HTN, no allergies BP175/105, HR 115 O2 saturation 97% RA EKG shows anterior STEMI ASA - yes PCI – if can be done in <60 minutes from presentation Otherwise lytics Oxygen – if low NTG sl iv -yes B blocker - yes Heparin - yes Morphine – after NTG Clopidogrel - yes GIIa/IIIb inhibitor - if PCI?

What can go wrong? Hypotension from nitrates Arrhythmias Heart failure/cardiogenic shock Bleeding/CVA

Questions?

Fake MI workshop - Roger Suss What is the likelihood of ACS? What else should be on the differential diagnosis? Are you critical of your colleagues record keeping? Suggest management plan. Are other options reasonable?